[1] 李广灿.我国15种恶性肿瘤10年发病趋势分析[J].肿瘤防治研究,1994,21(6):388.[2] Kulkarni RK,Pani KC,Neuman C,et al.Polylactic acid for surgical implants.Arch Surg.1976;93(5):839-843.[3] 张冬.靶向缓释聚丙交酯微球[D].黑龙江:黑龙江大学,2005:1-86.[4] 王军红.药物释放系统(DDS)的应用现状及发展对策[D].北京:中国人民解放军军事医学科学院,2005:1-88.[5] Laube BL,Georgopoulos A,Adams GK 3rd.Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients.JAMA.1993;269(16):2106-2109.[6] Jendle JH,Karlberg BE.Intrapulmonary administration of insulin to healthy volunteers.J Intern Med.1996;240(2):93-98.[7] Ferraz MP,Mateus AY,Sousa JC,et al.Nanohydroxyapatite microspheres as delivery system for antibiotics: release kinetics, antimicrobial activity, and interaction with osteoblasts.J Biomed Mater Res A.2007;81(4):994-1004.[8] von Eiff C,Bettin D,Proctor RA,et al.Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis.Clin Infect Dis.1997;25(5):1250-1251.[9] 张万国,蒋雪涛,朱才娟,等.肺靶向利福平聚乳酸微球的研究[J].药学学报,1998,33(1):442.[10] 张万国,胡晋红,蒋雪涛,等.聚乳酸相对分子量对利福平微球及其药物分布状态的影响[J].解放军药学学报,2001,17(2):59-61.[11] 丁红,邢桂琴,谢茵.阿霉素明胶微球的制备与特性研究[J].中国医院药学杂志,2000,20(7):387-389.[12] 崔一民,鲁云兰,王培玉.利福平白蛋白微球的研制[J].中国医院药学杂志,1999,19(3):131-132.[13] 中国知网.中国学术期刊总库[DB/OL].2012-08-10. https://www.cnki.net[14] SCI数据库.Web of Sciencevia ISI Web of Knowledge[DB/OL]. 2012-08-10.http://ip-science.thomsonreuters.com/mjl. [15] Sham JO, Zhang Y, Finlay WH,et al.Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.Int J Pharm. 2004; 269(2):457-467.[16] Carpenter ZK, Williamson ED, Eyles JE.Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu. Control Release. 2005;104(1):67-77. [17] Kwon MJ, Bae JH, Kim JJ,et al.Long acting porous microparticle for pulmonary protein delivery.Int J Pharm. 2007;333(1-2):5-9.[18] Ungaro F, De Rosa G, Miro A,et al.Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs.Eur J Pharm Sci.2006;28(5):423-432.[19] Jalil R,Nixon JR.Microencapsulation using poly (L-lactic acid) II: Preparative variables affecting microcapsule properties.J Microencapsul.1990;7(1):25-39.[20] 石红建,王杰,施海彬,等.葡聚糖微球经微导管栓塞术中应用参数的实验研究[J].南通医学院学报,2003,23(1):6-8.[21] 李志平.干扰素α-2b缓释微球及干粉吸入剂的研究[D].北京:中国人民解放军军事医学科学院,2007:1-135.[22] 李凤前,陆彬,杨红,等.汉防己甲素缓释微囊肺靶向给药系统的研究[J].药学学报,2001,36(3):220-223.[23] Muttil P,Kaur J,Kumar K,et al.Inhalable microparticles containing large payload of anti-tuberculosis drugs.Eur J Pharm Sci.2007;32(2):140-150.[24] 瞿文,陈庆华,赵瑞钦,等.丙氨瑞林生物可降解缓释微球注射剂的研究[J].中国医药工业杂志,2000,31(1):15.[25] 孔毅,吴如金,吴梧桐,等.高效毛细管电泳及其在蛋白质、多肽分析中的应用[J].药学进展,2000,24(4):204-208.[26] Morita T, Sakamura Y, Horikiri Y,et al.Evaluation of in vivo release characteristics of protein-loaded biodegradable microspheres in rats and severe combined immunodeficiency disease mice.J Control Release.2001;73(2-3):213-221.[27] Jiang G,Woo BH,Kang F,et al.Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.J Control Release.2002;79(1-3):137-145.[28] 叶晓霞,俞雄.多肽药物分析方法研究进展[J]. 中国医药工业杂志,2003,34(7):357-361.[29] 冯岚,郭健新,平其能,等.亮丙瑞林缓释微球的研究[J].中国新药与临床杂志,2004,23(10):680-683.[30] Wei G,Pettway GJ,McCauley LK,et al.The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres.Biomaterials. 2004;25(2):345-352.[31] 段宏,王光林,裴福兴,等.碱性成纤维细胞生长因子缓释微球对成骨细胞作用的实验研究[J].中华创伤杂志,2004,20(2):89-92.[32] Lagarce F,Garcion E,Faisant N,et al.Development and characterization of interleukin-18-loaded biodegradable microspheres.Int J Pharm.2006;314(2):179-188.[33] 李凤前,胡晋红,朱全刚.干粉末吸入环丙沙星缓释微球的制备及其体外释药调控[J].中国药学杂志,2002,37(2):110-113.[34] Cook RO,Pannu RK,Kellaway IW.Novel sustained release microspheres for pulmonary drug delivery.J Control Release.2005;104(1):79-90.[35] Ely L,Roa W,Finlay WH,et al.Effervescent dry powder for respiratory drug delivery.Eur J Pharm Biopharm.2007;65(3): 346-353.[36] Kaur J,Muttil P,Verma RK,et al.A hand-held apparatus for "nose-only" exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages. Eur J Pharm Sci.2008;34(1):56-65.[37] Rahman NA,Mathiowitz E.Localization of bovine serum albumin in double-walled microspheres.J Control Release. 2004;94(1):163-175.[38] Görner T,Gref R,Michenot D,et al.Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix.J Control Release.1999; 57(3):259-268.[39] Elkheshen SA,Radwan MA.Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.J Microencapsul.2000;17(4):425-435.[40] Yang J,Cleland JL.Factors affecting the in vitro release of recombinant human interferon-gamma (rhIFN-gamma) from PLGA microspheres.J Pharm Sci.1997;86(8):908-914. |